Dextrometorfano (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dextrometorfano" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

6nih.gov

4^th place

8^th place

4doi.org

2^nd place

4^th place

3web.archive.org

1^st place

2nature.com

234^th place

190^th place

1webcitation.org

24^th place

18^th place

1blackwell

low place

1usdoj.gov

2,755^th place

4,904^th place

1umd.edu

1,747^th place

2,256^th place

1dot.gov

1,690^th place

3,747^th place

1who.int

195^th place

150^th place

1aspetjournals.org

6,663^rd place

6,453^rd place

1sagepub.com

731^st place

660^th place

1erowid.org

3,887^th place

3,961^st place

aspetjournals.org

dmd.aspetjournals.org

«Comparative Contribution to Dextromethorphan Metabolism by Cytochrome P450 Isoforms in Vitro: Can Dextromethorphan Be Used as a Dual Probe for Both CYP2D6 and CYP3A Activities?». Consultado em 10 de agosto de 2008

blackwell

«Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration». Journal of Veterinary Pharmacology and Therapeutics. Consultado em 2 de maio de 2009. Arquivado do synergy.com/doi/abs/10.1111/j.1365-2885.2004.00608.x?cookieSet=1&journalCode=jvp original Verifique valor |url= (ajuda) em 5 de fevereiro de 2012

doi.org

dx.doi.org

Olney J, Labruyere J, Price M (1989). «Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs». Science. 244 (4910): 1360–2. PMID 2660263. doi:10.1126/science.2660263
Linda Nguyen, Kelan L Thomas, Brandon P Lucke-Wold, John Z Cavendish, Molly S Crowe, Rae R Matsumoto (2016). «Dextromethorphan: An Update on Its Utility for Neurological and Neuropsychiatric Disorders». J. Pharmacol. Exp. Ther. PMID 26826604. doi:10.1016/j.pharmthera.2016.01.016
Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Zhang W, Hong JS, Liu B (20 de janeiro de 2004). «Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase». The FASEB Journal. PMID 14734632. doi:10.1096/fj.03-0983fje

doi.org

https://doi.org/10.1016/j.pharmthera.2016.04.010

dot.gov

nhtsa.dot.gov

«Dextromethorphan». NHTSA. Consultado em 2 de maio de 2009. Arquivado do original em 12 de abril de 2010

erowid.org

nature.com

«British Journal of Pharmacology — The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via [sigma]1 receptor activation: comparison with the effects of dextromethorphan». Consultado em 16 de julho de 2007
«Clinical Pharmacology & Therapeutics — Abstract of article: The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans[ast]». Consultado em 16 de julho de 2007

nih.gov

ncbi.nlm.nih.gov

Brooks B, Thisted R, Appel S, Bradley W, Olney R, Berg J, Pope L, Smith R (2004). «Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial». Neurology. 63 (8): 1364–70. PMID 15505150
Olney J, Labruyere J, Price M (1989). «Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs». Science. 244 (4910): 1360–2. PMID 2660263. doi:10.1126/science.2660263
Hargreaves R, Hill R, Iversen L. «Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuronal morphology». Acta Neurochir Suppl (Wien). 60: 15–9. PMID 7976530
Hernandez SC, Bertolino M, Xiao Y, Pringle KE, Caruso FS, Kellar KJ (2000). «Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors». J. Pharmacol. Exp. Ther. 293 (3): 962–7. PMID 10869398
Linda Nguyen, Kelan L Thomas, Brandon P Lucke-Wold, John Z Cavendish, Molly S Crowe, Rae R Matsumoto (2016). «Dextromethorphan: An Update on Its Utility for Neurological and Neuropsychiatric Disorders». J. Pharmacol. Exp. Ther. PMID 26826604. doi:10.1016/j.pharmthera.2016.01.016
Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Zhang W, Hong JS, Liu B (20 de janeiro de 2004). «Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase». The FASEB Journal. PMID 14734632. doi:10.1096/fj.03-0983fje

sagepub.com

jcp.sagepub.com

«The polymorphic metabolism of dextromethorphan (abstract)». Consultado em 10 de agosto de 2008. Arquivado do original em 7 de dezembro de 2008

umd.edu

cesar.umd.edu

Dextromethorphan (DXM) | CESAR

usdoj.gov

deadiversion.usdoj.gov

«DEXTROMETHORPHAN (Street Names: DXM, CCC, Triple C, Skittles, Robo, Poor Man's PCP)». Consultado em 2 de maio de 2009. Arquivado do original em 21 de julho de 2011

web.archive.org

«DEXTROMETHORPHAN (Street Names: DXM, CCC, Triple C, Skittles, Robo, Poor Man's PCP)». Consultado em 2 de maio de 2009. Arquivado do original em 21 de julho de 2011
«Dextromethorphan». NHTSA. Consultado em 2 de maio de 2009. Arquivado do original em 12 de abril de 2010
«The polymorphic metabolism of dextromethorphan (abstract)». Consultado em 10 de agosto de 2008. Arquivado do original em 7 de dezembro de 2008

webcitation.org

«Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration». Journal of Veterinary Pharmacology and Therapeutics. Consultado em 2 de maio de 2009. Arquivado do synergy.com/doi/abs/10.1111/j.1365-2885.2004.00608.x?cookieSet=1&journalCode=jvp original Verifique valor |url= (ajuda) em 5 de fevereiro de 2012

who.int

whqlibdoc.who.int

WHO Expert Committee on Drug Dependence (1970). «Seventeenth Report» (PDF). World Health Organization. Consultado em 29 de dezembro de 2008